GHRH and Cognitive impairment: In a phase 2 clinical trial, it was found that systemic administration of growth hormone-releasing hormone (GHRH), present in the blood of young individuals, appears to beneficially affect cognitive function in healthy older humans and adults with mild cognitive impairment (MCI) (Baker et al. 2012).